[go: up one dir, main page]

Follow
Daniel A Haber
Daniel A Haber
Professor of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School
Verified email at mgh.harvard.edu
Title
Cited by
Cited by
Year
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non–small-cell lung cancer to gefitinib
TJ Lynch, DW Bell, R Sordella, S Gurubhagavatula, RA Okimoto, ...
New England Journal of Medicine 350 (21), 2129-2139, 2004
146432004
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development
M Okano, DW Bell, DA Haber, E Li
Cell 99 (3), 247-257, 1999
80941999
Anaplastic lymphoma kinase inhibition in non–small-cell lung cancer
EL Kwak, YJ Bang, DR Camidge, AT Shaw, B Solomon, RG Maki, SHI Ou, ...
New England Journal of Medicine 363 (18), 1693-1703, 2010
56312010
Isolation of rare circulating tumour cells in cancer patients by microchip technology
S Nagrath, LV Sequist, S Maheswaran, DW Bell, D Irimia, L Ulkus, ...
Nature 450 (7173), 1235-1239, 2007
46642007
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
W Yang, J Soares, P Greninger, EJ Edelman, H Lightfoot, S Forbes, ...
Nucleic acids research 41 (D1), D955-D961, 2012
41492012
Epidermal growth factor receptor mutations in lung cancer
SV Sharma, DW Bell, J Settleman, DA Haber
Nature Reviews Cancer 7 (3), 169-181, 2007
41082007
Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis
N Aceto, A Bardia, DT Miyamoto, MC Donaldson, BS Wittner, JA Spencer, ...
Cell 158 (5), 1110-1122, 2014
29382014
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition
M Yu, A Bardia, BS Wittner, SL Stott, ME Smas, DT Ting, SJ Isakoff, ...
science 339 (6119), 580-584, 2013
29312013
Systematic identification of genomic markers of drug sensitivity in cancer cells
MJ Garnett, EJ Edelman, SJ Heidorn, CD Greenman, A Dastur, KW Lau, ...
Nature 483 (7391), 570-575, 2012
28672012
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
M Meyerson, CM Counter, EN Eaton, LW Ellisen, P Steiner, SD Caddle, ...
cell 90 (4), 785-795, 1997
26241997
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
KM Call, T Glaser, CY Ito, AJ Buckler, J Pelletier, DA Haber, EA Rose, ...
Cell 60 (3), 509-520, 1990
24761990
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
S Maheswaran, LV Sequist, S Nagrath, L Ulkus, B Brannigan, CV Collura, ...
New England Journal of Medicine 359 (4), 366-377, 2008
22262008
A landscape of pharmacogenomic interactions in cancer
F Iorio, TA Knijnenburg, DJ Vis, GR Bignell, MP Menden, M Schubert, ...
Cell 166 (3), 740-754, 2016
21792016
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
R Sordella, DW Bell, DA Haber, J Settleman
Science 305 (5687), 1163-1167, 2004
21462004
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
SL Stott, CH Hsu, DI Tsukrov, M Yu, DT Miyamoto, BA Waltman, ...
Proceedings of the National Academy of Sciences 107 (43), 18392-18397, 2010
20642010
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
VS Viswanathan, MJ Ryan, HD Dhruv, S Gill, OM Eichhoff, ...
Nature 547 (7664), 453-457, 2017
19362017
Circulating tumor cells: approaches to isolation and characterization
M Yu, S Stott, M Toner, S Maheswaran, DA Haber
Journal of Cell Biology 192 (3), 373-382, 2011
14082011
Inertial focusing for tumor antigen–dependent and–independent sorting of rare circulating tumor cells
E Ozkumur, AM Shah, JC Ciciliano, BL Emmink, DT Miyamoto, E Brachtel, ...
Science translational medicine 5 (179), 179ra47-179ra47, 2013
13142013
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
DW Bell, JM Varley, TE Szydlo, DH Kang, DCR Wahrer, KE Shannon, ...
Science 286 (5449), 2528-2531, 1999
12731999
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
EL Kwak, R Sordella, DW Bell, N Godin-Heymann, RA Okimoto, ...
Proceedings of the National Academy of Sciences 102 (21), 7665-7670, 2005
12222005
The system can't perform the operation now. Try again later.
Articles 1–20